Literature DB >> 28678144

Relationship of mean platelet volume to lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris.

Ender Ornek1, Alparslan Kurtul.   

Abstract

BACKGROUND: In patients with coronary artery disease, coronary collateral circulation (CCC) develops as an adaptation to ischemia and contributes toward reduction of cardiovascular events. Recently, the mean platelet volume-to-lymphocyte ratio (MPVLR) has emerged as a novel and readily available marker of inflammation and thrombosis. This study aimed to investigate the relationship between MPVLR and development of CCC. PATIENTS AND METHODS: A total of 332 patients with stable angina pectoris undergoing coronary arteriography were enrolled and divided on the basis of the development of CCC into two groups: group with adequate CCC (n=243) and group with impaired CCC (n=89). Routine complete blood count parameters and high-sensitivity C-reactive protein (hsCRP) were measured before coronary arteriography.
RESULTS: Both MPVLR and hsCRP levels were higher in the impaired CCC group (P<0.001 and P=0.007, respectively). Multivariate logistic regression analysis indicated that MPVLR was associated independently with impaired CCC [odds ratio (OR): 1.706, 95% confidence interval (CI): 1.328-2.192, P<0.001]. In addition to MPVLR, hsCRP (OR: 1.144, P=0.030) and fasting blood glucose (OR: 1.007, P=0.049) were also associated independently with impaired CCC. In receiver operating characteristics curve analysis, an optimal cut-off point for MPVLR (4.47) was found to predict the presence of good CCC with a sensitivity of 75.3% and a specificity of 71.2% (P<0001).
CONCLUSION: Our findings suggest that measurement of MPVLR may predict the development of CCC in patients with stable coronary artery disease. An increased MPVLR is associated independently with impaired CCC in these patients.

Entities:  

Mesh:

Year:  2017        PMID: 28678144     DOI: 10.1097/MCA.0000000000000530

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  6 in total

1.  Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis.

Authors:  JianPing Wu; WeiLin Mao; XinKe Li
Journal:  Gastroenterol Res Pract       Date:  2020-07-02       Impact factor: 2.260

2.  Mean platelet volume to lymphocyte ratio and platelet distribution width to lymphocyte ratio in Iraqi patients diagnosed with systemic lupus erythematosus.

Authors:  Nabaa Ihsan Awadh; Faiq Isho Gorial; Reem Abbas Hammadi; Mariam K Ibrahim; Saba Hussein Majeed; Maab Jasim Mohammed
Journal:  Reumatologia       Date:  2022-07-13

3.  A new marker of short-term mortality and poor outcome in patients with acute ischemic stroke: Mean platelet volume-to-lymphocyte ratio.

Authors:  Fan Wu; Qian Wang; Yingli Qiao; Qing Yu; Fuyuan Wang
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

4.  Correlation of hematological indices and ratios derived from them with FIQR scores in fibromyalgia.

Authors:  Marwan Salih Mohammud Al-Nimer; Talar Ahmad Merza Mohammad
Journal:  Pak J Med Sci       Date:  2018 Sep-Oct       Impact factor: 1.088

5.  Association of mean platelet volume and red blood cell distribution width with coronary collateral development in stable coronary artery disease.

Authors:  Isa Sincer; Yilmaz Gunes; Asli Kurtar Mansiroglu; Mehmet Cosgun; Gulali Aktas
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-09-21       Impact factor: 1.426

6.  Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy.

Authors:  Marcin Życzkowski; Zbigniew Kaletka; Pawel Rajwa; Grzegorz Rempega; Paweł Stelmach; Rafał Bogacki; Olga Łach-Wojnarowicz; Ewa Paradysz
Journal:  Int Urol Nephrol       Date:  2020-01-17       Impact factor: 2.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.